As FGF-23 concentration reflects phosphorus accumulation in CKD patients [13], and because hyperphosphatemia increases significantly the CVD risk [40, 41], FGF-23 may be a better predictor of CKD progression (time to doubling of serum creatinine) than calcium or phosphate levels. The gene discussed is FGF23; the disease is chronic kidney disease.